Clinical Trials Directory

Trials / Unknown

UnknownNCT05434286

Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury

Status
Unknown
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Point-of-care echocardiography (POC-Echo) is used to determine left ventricular systolic and diastolic dysfunction (LVDD), inferior vena cava (IVC) dynamics and volume status in cirrhosis and Acute-on-chronic liver failure ACLF accurately. We will assess IVC dynamics, LV systolic function \[LV ejection fraction (EF) \& cardiac output (CO)\], and diastolic dysfunction (E/e', e' and E/A ratio) and urinary biomarkers (cystatin C and NGAL) in patients with cirrhosis and ACLF with hepatorenal syndrome-acute kidney injury (HRS-AKI).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiographic assessmentPOC-Echocardiography to assess dynamic changes in cardiac output to assess therapeutic responses with albumin and terlipressin

Timeline

Start date
2021-12-15
Primary completion
2023-03-15
Completion
2023-06-15
First posted
2022-06-28
Last updated
2023-05-01

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT05434286. Inclusion in this directory is not an endorsement.